Greg Wujek

Greg Wujek is Chief Commercial Officer of Castle Creek Biosciences, Inc. Mr. Wujek has more than 30 years of industry experience in executive management, sales, market access, marketing, and business development. Previously, Mr. Wujek served as Chief Executive Officer of Castle Creek Pharmaceuticals. Prior to joining Castle Creek, he managed and developed successful strategies for Zimmer Biomet/ Biologics Division’s first prescription injectable product, Gel-One®. Prevously, Mr.Wujek led the build out of Savient’s biologics arm taking responsibility for Operations, Sales and Managed Care in support of EUFLEXXA®, the company’s first biologic launch. Prior to Savient, Mr. Wujek was responsible for managing the team that successfully launched ALTOPREV® and FORTAMET® at Andrex Laboratories. Mr. Wujek began his career at Forest Laboratories where he quickly elevated himself and took responsibility for the Managed Care department in support of the company’s first blockbuster, TIAZAC®. He graduated from Illinois State University with a B.S. in political science.